Back to search

Article

Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid <i>in vivo</i> functional genomics

2019-03-26

Abstract excerpt

Patient-derived xenografts (PDXs) constitute a powerful set of preclinical models for in vivo cancer research, reflecting the spectrum of genomic alterations and therapeutic liabilities of human cancers 1-4 . In contrast to either cancer cell lines or genetically engineered mouse models, the utility of PDXs has been limited by the inability to perform targeted genome editing of these tumors. To address this limi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cbb6934f-7ff2-5c23-96f5-c4e75c9643b5
DOI
10.1101/588921
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid <i>in vivo</i> functional genomicsDOI 10.1101/588921
Select a neighboring publication to make it the new centre.